To include your compound in the COVID-19 Resource Center, submit it here.
Santen will acquire fellow ophthalmic company Novagali for €6.15 per share, or about €100 million ($134.2 million). The price is a
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury